Cyberonics Incorporated Company Profile - Aug 14, 2011 by WrightReports

VIEWS: 12 PAGES: 10

Cyberonics, Inc. (Cyberonics), is a neuromodulation company engaged in the design, development and commercialization of implantable medical devices that provide a therapy, vagus nerve stimulation therapy (VNS Therapy), for the treatment of refractory epilepsy and treatment-resistant depression. VNS Therapy System includes a generator to provide the appropriate stimulation to the vagus nerve; a lead that connects the generator to the vagus nerve; associated equipment to assist with implantation surgery; equipment to assist with setting the stimulation parameters particular to the patient; appropriate instruction manuals, and magnets to suspend or induce stimulation manually. The generator and lead are surgically implanted into patients, generally on an outpatient basis. The battery contained in the generator has a finite life, which varies according to the model, the stimulation parameters and the settings used for each patient.

More Info
									Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Cyberonics Incorporated
                                                                                         440 Wheelers Farms Road
                                                                                         Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in U.S. Dollars

                                 Wright Quality Rating:CANN                                Key Data

   Cyberonics, Inc. (Cyberonics) is a neuromodulation company engaged in the design,       Ticker:
   development, sales and marketing of implantable medical devices that provide a          CYBX
   therapy, vagus nerve stimulation therapy (VNS Therapy), for the treatment of
   refractory epilepsy and treatment-resistant depression. VNS Therapy System              2011 Sales:
   includes a generator to provide the appropriate stimulation to the vagus nerve; a
                                                                                           190,464,398
   lead that connects the generator to the vagus nerve; associated equipment to
   assist with implantation surgery; equipment to assist with setting the stimulation
   parameters particular to the patient; appropriate instruction manuals, and magnets      Major Industry:
   to suspend or induce stimulation manually. The generator and lead are surgically        Drugs, Cosmetics & Health
   implanted into patients, generally on an outpatient basis. The battery contained in     Care
   the generator has a finite life, which varies according to the model, the stimulation
   parameters and the settings used for each patient.                                      Sub Industry:
                       Stock Chart                                Officers                 Medical, Surgical & Dental
                                                         President & Chief Executive       Suppliers
                                                               Daniel J. Moore
                                                                                           Country:
                                                              Vice President Finance &     United States
                                                               Chief Financial Officer
                                                                  Gregory H. Browne        Currency:
                                                                                           U.S. Dollars
                                                         Vice President, Secretary &
                                                              General Counsel
                                                                                           Fiscal Year Ends:
                                                                David S. Wise
                                                                                           April

                                                                                           Employees
                                                                                           484

                                                                                           Exchanges:
                                                                                           NAS

                                                                                           Share Type:
                                                                                           Common
             Stock Price (8/5/2011): 25.74
               Recent stock performance
                                                                                           Market Capitalization:
                  1 Week       -5.2%
                                                                                           722,990,474
                  4 Weeks     -12.8%
                  13 Weeks    -23.1%
                  52 Weeks     11.4%                                                 
								
To top